Safety And Activity Of A First-In-Class Oral Hif2-Alpha Inhibitor, Pt2385, In Patients With First Recurrent Glioblastoma (Gbm).Roy E. Strowd,Benjamin M. Ellingson,Patrick Y. Wen,Manmeet Singh Ahluwalia,Anna F. Piotrowski,Arati Suvas Desai,Jennifer Leigh Clarke,Frank S. Lieberman,Serena Desideri,Louis B. Nabors,Xiaobu Ye,Stuart A. GrossmanJOURNAL OF CLINICAL ONCOLOGY（2019）引用 14|浏览38暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
